PEDIATRICS Vol. 117 No. 1 January 2006, pp. 239-240 (doi:10.1542/peds.2005-2790)
POLICY STATEMENT |
Recommended Childhood and Adolescent Immunization Schedule—United States, 2006
Committee on Infectious DiseasesThe annual recommended childhood and adolescent immunization schedule for January–December 2006 was approved by the American Academy of Pediatrics, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention, and the American Academy of Family Physicians is issued for 2006. This schedule reflects current recommendations for use of US Food and Drug Administration–licensed vaccines. The 2006 schedule reflects the following major changes.
- The fourth dose of diphtheria and tetanus toxoids and acellular pertussis (DTaP) may be administered as early as 12 months of age, provided 6 months have elapsed since the third dose and the child is unlikely to return at 15 to 18 months of age.
- A single dose of an adolescent preparation of tetanus and diphtheria toxoids and acellular pertussis vaccine (Tdap) is recommended at 11 to 12 years of age for those who have completed the recommended DTP/DTaP series and have not received a tetanus-diphtheria (Td) booster dose. Adolescents 13 to 18 years of age who missed the 11- to 12-year-old Td or Tdap booster dose or in whom it has been 5 years or more since the Td booster dose also should receive a single dose of Tdap if they have completed the DTP/DTaP series.1
- A single dose of meningococcal conjugate vaccine (MCV4) is recommended for all 11- to 12-year-olds as well as unimmunized adolescents at high school entry (15 years of age). All college freshman who will be living in a dormitory also should be immunized, preferably with MCV4, although meningococcal polysaccharide vaccine is an acceptable alternative.2
- Influenza vaccine should be administered annually to all high-risk children, including children with conditions that can compromise respiratory function or handling of respiratory secretions or that can increase the risk for aspiration.
- Hepatitis A vaccine, licensed for administration to children 12 months of age and older, is now recommended for universal administration to all children at 1 to 2 years (12 to 23 months) of age and for certain high-risk groups. The 2 doses in the series should be separated by at least 6 months.
Clinically significant adverse events that follow immunization should be reported to the Vaccine Adverse Event Reporting System (VAERS). Guidance about how to obtain and complete a VAERS form can be obtained on the Internet at www.vaers.hhs.gov or by calling 800-822-7967. Information on new vaccine releases, vaccine supplies, and statements on specific vaccines can be found at www.aap.org and www.cdc.gov/nip. Vaccine-related updates are available online at www.aapredbook.org.
| Committee on Infectious Diseases, 2005–2006 |
|---|
|
|
|---|
Keith R. Powell, MD, Chairperson
Robert S. Baltimore, MD
Henry H. Bernstein, DO
Joseph A. Bocchini, Jr, MD
John S. Bradley, MD
Michael T. Brady, MD
Penelope H. Dennehy, MD
Robert W. Frenck, Jr, MD
David W. Kimberlin, MD
Sarah S. Long, MD
Julia A. McMillan, MD
Lorry G. Rubin, MD
| Liaisons |
|---|
|
|
|---|
Richard D. Clover, MD
American Academy of Family Physicians
Stephen L. Cochi, MD
Centers for Disease Control and Prevention
Joanne Embree, MD
Canadian Paediatric Society
Marc A. Fischer, MD
Centers for Disease Control and Prevention
Mamodikoe Makhene, MD
National Institutes of Health
Douglas R. Pratt, MD
Food and Drug Administration
Benjamin Schwartz, MD
National Vaccine Program Office
Jeffrey R. Starke, MD
American Thoracic Society
Jack Swanson, MD
Practice Action Group
| Ex Officio |
|---|
|
|
|---|
Larry K. Pickering, MD
Red Book Editor
| Consultant |
|---|
|
|
|---|
Edgar O. Ledbetter, MD
| Staff |
|---|
|
|
|---|
Alison Siwek, MPH
| REFERENCES |
|---|
|
|
|---|
- American Academy of Pediatrics, Committee on Infectious Disease. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
Pediatrics. 2006; In press
- American Academy of Pediatrics, Committee on Infectious Diseases. Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients. Pediatrics. 2005;116 :496 –505
- American Academy of Pediatrics, Committee on Infectious Diseases. Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients. Pediatrics. 2005;116 :496 –505
PEDIATRICS (ISSN 1098-4275). ©2006 by the American Academy of Pediatrics
The following policy statement is a revision:
- Recommended Immunization Schedules for Children and Adolescents--United States, 2007
Pediatrics 119: 207-208.[Full Text]
The following policy statement has been revised:
- Recommended Childhood and Adolescent Immunization Schedule: United States, 2005
Pediatrics 115: 182-182.[Full Text]
This article has been cited by other articles:
![]() |
G. M. Lee, S. A. Lorick, E. Pfoh, K. Kleinman, and D. Fishbein Adolescent Immunizations: Missed Opportunities for Prevention Pediatrics, October 1, 2008; 122(4): 711 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Hatfield, M. E. Gusic, A.-M. Dyer, and R. C. Polomano Analgesic Properties of Oral Sucrose During Routine Immunizations at 2 and 4 Months of Age Pediatrics, February 1, 2008; 121(2): e327 - e334. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Weber, J. A. Taylor, R. L. McCarty, and A. Johnson-Grass Frequency and Characteristics of Pediatric and Adolescent Visits in Naturopathic Medical Practice Pediatrics, July 1, 2007; 120(1): e142 - e146. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Pickering, G. Wallace, and L. Rodewald Too Hot, Too Cold: Issues With Vaccine Storage Pediatrics, October 1, 2006; 118(4): 1738 - 1739. [Full Text] [PDF] |
||||
![]() |
M. B. Aldous Is it Exposure to Smoke or to Smokers that Increases the Risk of Meningococcal Disease? AAP Grand Rounds, August 1, 2006; 16(2): 17 - 17. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






